Sansure Biotech Inc. (SHA:688289)
China · Delayed Price · Currency is CNY 18.34
+0.26 (1.44%)
At close: Mar 6, 2026
Sansure Biotech Revenue
In the year 2025, Sansure Biotech had annual revenue of 1.65B CNY with 13.04% growth. Sansure Biotech had revenue of 404.11M in the quarter ending December 31, 2025, a decrease of -5.02%.
Revenue
1.65B
Revenue Growth
+13.04%
P/S Ratio
6.39
Revenue / Employee
702.58K
Employees
2,409
Market Cap
10.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.65B | 190.18M | 13.04% |
| Dec 31, 2024 | 1.46B | 450.94M | 44.78% |
| Dec 31, 2023 | 1.01B | -5.44B | -84.39% |
| Dec 31, 2022 | 6.45B | 1.94B | 42.88% |
| Dec 31, 2021 | 4.51B | -248.42M | -5.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Truking Technology | 5.55B |
| Tofflon Science and Technology Group | 5.22B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.19B |
| Autek China | 1.82B |
| Eyebright Medical Technology (Beijing) | 1.48B |
| BMC Medical | 1.05B |
| Aidite (Qinhuangdao) Technology | 993.58M |
| Mingyue Optical Lens | 813.39M |